Skip to main content
Signal8

Trotta Matteo

SEC insider (Form 3/4/5 filer). CIK 0002015975. EVP, GM, Dermatology US at INCYTE CORP (INCY). 6 reported Form 4/5 transactions since Sep 2024; latest on Mar 25, 2026. Located in WILMINGTON, DE.

Companies Trotta Matteo has filed insider reports for

  • INCYTE CORP (INCY): Officer, EVP, GM, Dermatology US
Trotta Matteo profile photo

Trotta Matteo

CIK: 0002015975

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INCYTE CORP logo
INCY

INCYTE CORP

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • INCYTE CORP logo
    INCY

    INCYTE CORP

    Mar 25, 2026
    Tax Payment
    Direct
    537 shares at avg. $92.23$50K
  • INCYTE CORP logo
    INCY

    INCYTE CORP

    Jan 16, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    8.5K shares-
  • INCYTE CORP logo
    INCY

    INCYTE CORP

    Jul 15, 2025
    Tax Payment
    Direct
    182 shares at avg. $68.25$12K
  • INCYTE CORP logo
    INCY

    INCYTE CORP

    Jul 15, 2025
    Award
    Direct
    5.3K shares-
  • INCYTE CORP logo
    INCY

    INCYTE CORP

    Mar 25, 2025
    Tax Payment
    Direct
    537 shares at avg. $62.08$33K
  • INCYTE CORP logo
    INCY

    INCYTE CORP

    Jan 17, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    5.4K shares-

1-6 of 6